Global X HealthTech ETF (HEAL)

The immediate outlook is mixed, driven by a divergence between recent price strength and the broader technical backdrop. Over the last two weeks, the ETF has rallied nearly 10%, climbing from roughly $25.80 to $28.24, which has pushed the price above both the 50-day and 200-day moving averages. This recent momentum suggests buyers are stepping in at these levels. However, the statistical forecasting model flags a slight downside bias (-2.72%) over the next 45 days, creating a tension between the recent pop and the medium-term trend. The options market offers no clarity, with traders holding deep in-the-money calls but avoiding out-of-the-money bets entirely. Looking further ahead, the long-term picture remains challenging despite the recent recovery. The asset has suffered a brutal 45% decline over the past four years, characterized by three consecutive years of negative returns before a single year of recovery. While the most recent annual return was positive (+16.86%), the path to get here involved significant structural damage. The market has not yet fully validated a sustainable turnaround, keeping the long-term rating neutral. Investors should view the recent rally as a potential stabilization point rather than the start of a multi-year bull run, given the heavy weight of prior losses.